Literature DB >> 23721135

Diagnostic accuracy of whole-body diffusion-weighted magnetic resonance imaging with 3.0 T in detection of primary and metastatic neoplasms.

Sinan Akay1, Murat Kocaoglu, Ozdes Emer, Bilal Battal, Nuri Arslan.   

Abstract

INTRODUCTION: To discuss the accuracy of the whole-body diffusion-weighted imaging with background body signal suppression (WB-DWIBS) technique performed in the 3.0-T system.
METHODS: We studied 17 patients who underwent positron emission tomography (PET)/CT and WB-DWIBS examinations for staging their diseases. The DWIBS pulse and echo-planar imaging-short T1 inversion recovery single-shot pulse sequences were performed for WB-DWIBS. A PET/CT scan was performed with 18-fluorodeoxyglucose. The lesions were localised and counted in both of the examinations, and WB-DWIBS was evaluated for the neoplastic tissue detection rate, while PET/CT was accepted as the reference standard modality.
RESULTS: The WB-DWIBS scan had a room occupation time of 32-35 min. All of the metastasis positive patients (n = 12) detected with PET/CT were also detected with WB-DWIBS (100%). In our patient group, there were a total of 109 bone metastases on PET/CT scans, and 93 of them (85.3%) were demonstrated with WB-DWIBS. We detected 128 metastatic lymph nodes on PET/CT, and 123 of them (96.3%) were demonstrated with WB-DWIBS. There were a total of 17 liver metastases on PET/CT, and 15 of them (88.2%) were detected with WB-DWIBS. There was no statistically significant difference between the two imaging modalities in detecting bone, lymph node and liver metastases (P > 0.05).
CONCLUSIONS: WB-DWIBS is a non-invasive technique that may successfully detect the spreading of the tumoural tissue in cancer patients when compared with PET/CT.
© 2013 The Authors. Journal of Medical Imaging and Radiation Oncology © 2013 The Royal Australian and New Zealand College of Radiologists.

Entities:  

Mesh:

Year:  2013        PMID: 23721135     DOI: 10.1111/1754-9485.12026

Source DB:  PubMed          Journal:  J Med Imaging Radiat Oncol        ISSN: 1754-9477            Impact factor:   1.735


  6 in total

Review 1.  Lymphoma: current status of clinical and preclinical imaging with radiolabeled antibodies.

Authors:  Christopher G England; Lixin Rui; Weibo Cai
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-11-14       Impact factor: 9.236

2.  Diagnostic accuracy of diffusion-weighted whole-body imaging with background body signal suppression/T2-weighted image fusion for the detection of abdominal solid cancer.

Authors:  Minoru Tomizawa; Fuminobu Shinozaki; Kazunori Fugo; Satomi Tanaka; Takafumi Sunaoshi; Daisuke Kano; Eriko Sugiyama; Misaki Shite; Ryouta Haga; Yoshiya Fukamizu; Toshiyuki Fujita; Satoshi Kagayama; Rumiko Hasegawa; Akira Togawa; Yoshinori Shirai; Noboru Ichiki; Yuji Oshima; Naoto Koike; Yasuko Toshimitsu; Yasufumi Motoyoshi; Takao Sugiyama; Shigenori Yamamoto; Takashi Kishimoto; Naoki Ishige
Journal:  Exp Ther Med       Date:  2017-05-05       Impact factor: 2.447

Review 3.  Management of colorectal cancer presenting with synchronous liver metastases.

Authors:  Ajith K Siriwardena; James M Mason; Saifee Mullamitha; Helen C Hancock; Santhalingam Jegatheeswaran
Journal:  Nat Rev Clin Oncol       Date:  2014-06-03       Impact factor: 66.675

4.  Diagnostic efficacy of whole-body diffusion-weighted imaging in the detection of tumour recurrence and metastasis by comparison with 18F-2-fluoro-2-deoxy-D-glucose positron emission tomography or computed tomography in patients with gastrointestinal cancer.

Authors:  Jiaying Gong; Wuteng Cao; Zhanwen Zhang; Yanhong Deng; Liang Kang; Pan Zhu; Zhengjun Liu; Zhiyang Zhou
Journal:  Gastroenterol Rep (Oxf)       Date:  2014-11-17

5.  Prediction of nodal involvement in primary rectal carcinoma without invasion to pelvic structures: accuracy of preoperative CT, MR, and DWIBS assessments relative to histopathologic findings.

Authors:  Jun Zhou; Songhua Zhan; Qiong Zhu; Hangjun Gong; Yidong Wang; Desheng Fan; Zhigang Gong; Yanwen Huang
Journal:  PLoS One       Date:  2014-04-02       Impact factor: 3.240

6.  68Ga-PSMA 11 ligand PET imaging in patients with biochemical recurrence after radical prostatectomy - diagnostic performance and impact on therapeutic decision-making.

Authors:  B Grubmüller; P Baltzer; D D'Andrea; S Korn; A R Haug; M Hacker; K H Grubmüller; G M Goldner; W Wadsak; S Pfaff; J Babich; C Seitz; H Fajkovic; M Susani; P Mazal; G Kramer; S F Shariat; Markus Hartenbach
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-10-26       Impact factor: 9.236

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.